[Trial treatment of acute myeloblastic leukemia with the cytosine arabinoside-cyclophosphamide association. (Apropos of 30 cases)].
D000293:Adolescent; D000328:Adult; D001215:Asparaginase / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use*; D003561:Cytarabine / Q000627:therapeutic use*; D003630:Daunorubicin / Q000627:therapeutic use; D004357:Drug Synergism; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012075:Remission, Spontaneous
D003561:Cytarabine; D003520:Cyclophosphamide; D001215:Asparaginase; D003630:Daunorubicin
Essai de traitement des leucémies aiguës myéloblastiques par l'association cytosine-arabinoside-cyclophosphamide. (A propos de 30 observations.